Production Capacity Investment With Trial Result Updates

We consider the capital investment problem faced by a firm that must invest in capacity while gathering information about whether that capacity will actually be needed. Specifically, we are motivated by pharmaceutical firms, which face long horizons for clinical trials, “all-or-nothing” demand for new products depending on the outcome those clinical trials, long lead times for the construction of manufacturing capacity, and extremely high costs for construction of that capacity.